RISE AND FALL IN SARS-COV-2 GLOBAL PANDEMIC STRAIN RATE–AN OVERVIEW

  • ABDULLAH ANWA Department of Civil and Construction Engineering, National Taiwan University of Science and Technology, 106 Taipei, Taiwan, ROC, Department of Civil Engineering, Rajkiya Engineering College, Ambedkar Nagar, Uttar Pradesh, 224122, India
  • VISHAL SINGH CHANDEL Department of Applied Science and Humanities, Rajkiya Engineering College, Ambedkar Nagar, Uttar Pradesh, 224122, India
  • SATYENDRA PRATAP SINGH Department of Physics, AIAS, Amity University, Noida, Uttar Pradesh, 201301, India
  • SATYA PRAKASH SINGH Department of Pharmacy, Babu Sunder Singh College of Pharmacy, Nigohan, Uttar Pradesh, 226302, India
  • NEDA ANWAR Department of Dental Surgery, Career Institute of Medical Sciences and Hospital, Lucknow, India, 226020

Abstract

After its discovery in Hubei in China in December 2019, the deadly rise of modern coronavirus (COVID-19 or 2019-nCoV) has spread globally. SARS-CoV-2 disease COVID-19 has quickly spread worldwide, posing a serious threat to health and the economy. As of 25th January 2021, more than 100 million confirmed cases of 2,165,581 deaths have been reported by WHO and Worldometer. Many of the cases reported are caused by infection from human to human and are the carriers of this lethal coronavirus. Due to its calamitous nature, the whole world was under lockdown restricting all sorts of movements and means of transportation in hampering the countries economic balance. Presently, the world's endeavor to create and develop a safe and effective COVID-19 vaccine is bearing the fruit. A handful of vaccines now have been authorized around the globe and many more remain in the development phase. In addition, social isolation and knowledge of hygiene (facial masks and sanitizers) are potential methods of controlling the further dissemination of global pandemics COVID-19. This research article presents a brief overview of the catastrophic effect caused by COVID-19 disease globally and particularly in different states of India. Additionally, the article also discusses the recent variant of SARS-CoV-2 and its vulnerable impact. Furthermore, the article investigates the currently available vaccines and those in their development phase for the treatment of COVID-19 disease. This investigatory literature may provide comprehensive details on COVID-19 disease from its inception to grow and later fall in its strain rate.

Keywords: Coronavirus, COVID-19, 2019-nCoV, SARS-CoV-2, Wuhan, Vaccines

References

1. Bansal M, Walia MK. COVID 19-an overview on epidemiology, symptoms, prevention, management, treatment and role of health workers. Int J Appl Pharm 2020;12:36–41.
2. Diseases E, Tracker D, Careers E. In focus coronavirus [Internet]. Infectious Diseases Hub; 2020. Available from: https://www.id-hub.com/2020/03/17/in-focus-coronavirus/
3. Weiss SR, Navas Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 2005;69:635–64.
4. Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ, et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci 2020;6:315-31.
5. Niharika D, Niharika B, Aishwarya T, Nikitha A, Butool R, Ibrahim M, et al. Coronavirus-a virus in learning. Int J Curr Pharm Res 2020;12:7–10.
6. Centers for Disease Control and Prevention. Public Health Image Library (PHIL); 2020. Available from: https://phil.cdc.gov/Details.aspx?pid=23313 [Last accessed on 01 Jan 2021]
7. Du L, He Y, Zhou Y, Liu S, Zheng BJ. The spike protein of SARS-CoV-a target for vaccine and therapeutic development. Nat Rev Microbiol 2009;7:226–36.
8. Cavanagh D. Coronavirus avian infectious bronchitis virus. Vet Res 2007;38:281–97.
9. Ismail AMM, Tang Y, Saif YM. Pathogenicity of turkey coronavirus in turkeys and chickens. Avian Dis 2003;47:515–22.
10. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;24:490–502.
11. Zhou P, Fan H, Lan T, Yang X, Shi W, Zhang W, et al. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature 2018;556:255–8.
12. Gallagher TM, Buchmeier MJ. Coronavirus spike proteins in viral entry and pathogenesis. Virology 2001;279:371–4.
13. Tyrrell DAJ, Bynoe ML, Obst Drcog. Cultivation of novel type of common-cold virus in organ cultures. Br Med J 1965;1:1467–70.
14. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395:470–3.
15. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med 2020;382:727–33.
16. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Articles genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565–74.
17. Peiris JSM, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004;10:88–97.
18. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319–25.
19. Chan Yeung M, Xu R. SARS: epidemiology. Respirology 2003;8:9–14.
20. Raj VS, Osterhaus ADME, Fouchier RAM, Haagmans BL. MERS: emergence of a novel human coronavirus. Curr Opin Virol 2014;5:58–62.
21. Lee J, Chowell G, Jung E. A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the republic of korea: a retrospective analysis on control interventions and superspreading events. J Theor Biol 2016;408:118–26.
22. Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J 2019;16:1–22.
23. StatNano. Coronavirus Disease 2019 (COVID-19) Outbreak. StatNano; 2020. Available from: https://statnano.com/coronavirus-disease-outbreak-covid-19 [Last accessed on 01 Jan 2021]
24. World Health Organization. WHO Novel Coronavirus–Japan (ex-China). World Health Organization; 2020. Available from: https://www.who.int/csr/don/16-january-2020-novel-coronavirus-japan-ex-china/en/ [Last accessed on 01 Jan 2021]
25. World Health Organization. Novel Coronavirus (2019-nCoV) SITUATION REPORT-1; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf [Last accessed on 01 Jan 2021]
26. World Health Organization. Novel Coronavirus (2019-nCoV); 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200124-sitrep-4-2019-ncov.pdf?sfvrsn=9272d086_8 [Last accessed on 01 Jan 2021]
27. Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses 2020;12:1–8.
28. World Health Organization. WHO Timeline-COVID-19 this statement is updated on an ongoing. World Health Organization; 2020. p. 1–4. Available from: https://www.who.int/news-room/detail/08-04-2020-who-timeline---covid-19 [Last accessed on 01 Jan 2021]
29. World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report–11. World Health Organization; 2020. p. 1–15. Available from: https://www.who.int/docs/default-source/searo/timor-leste/17-02-2020-tls-sitrep-11-ncov-eng. pdf?sfvrsn=d7f73101_2 [Last accessed on 01 Jan 2021]
30. World Health Organization. WHO Statement regarding cluster of pneumonia cases in Wuhan, China. World Health Organization; 2020. p. 1–2. Available from: https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china [Last accessed on 01 Jan 2021]
31. Gorbalenya AE, Baker SC, Baric RS, Groot RJ De, Gulyaeva AA, Haagmans BL, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses–a statement of the coronavirus study group. bioRxiv. 2020:1–15. https://doi.org/10.1101/2020.02.07.937862
32. Ji W, Wang W, Zhao X, Zai J, Li X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J Med Virol 2020;92:433–40.
33. Cyranoski D. Did pangolins spread the China coronavirus to people? Nature 2020. https://doi.org/10.1038/d41586-020-00364-2
34. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019?nCoV) in Wuhan, China. J Med Virol 2020;92:441–7.
35. Enserink M. Update A bit chaotic. Christening of new coronavirus and its disease name create confusion. Science 2020. p. 1–4. Available from: https://www.sciencemag.org/news/2020/02/bit-chaotic-christening-new-coronavirus-and-its-disease-name-create-confusion [Last accessed on 01 Jan 2021]
36. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report-48. World Health Organization; 2020. p. 1–8. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4 [Last accessed on 01 Jan 2021]
37. Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, et al. CRISPR–Cas12-based detection of SARS-CoV-2. Nat Biotechnol 2020;38:870-4.
38. World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. World Health Organization; 2020. p. 1–10. Available from: https://apps.who.int/iris/bitstream/handle/10665/331329/WHO-COVID-19-laboratory-2020.4-eng.pdf [Last accessed on 01 Jan 2021]
39. Nguyen T, Duong Bang D, Wolff A. 2019 Novel coronavirus disease (covid-19): paving the road for rapid detection and point-of-care diagnostics. Micromachines. 2020;11:306.
40. Gorbalenya AE, Baker SC, Baric RS, Groot RJ de, Drosten C, Gulyaeva AA, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44.
41. Kupferschmidt K, Cohen J. Will novel virus go pandemic or be contained? Science 2020;367:610–1.
42. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579:1-8.
43. Adnan N, Nordin SM. How COVID 19 effect Malaysian paddy industry? Adoption of green fertilizer a potential resolution. Environ Dev Sustain; 2020. https://doi.org/10.1007/s10668-020-00978-6
44. Fehr AR, Channapannavar R, Perlman S. Middle east respiratory syndrome: Emergence of a pathogenic human coronavirus. Annu Rev Med 2017;68:387–99.
45. Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;588:1–10.
46. Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html [Last accessed on 01 Jan 2021]
47. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020;382:1177–9.
48. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382:1–3.
49. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv; 2020. Available from: https://www.medrxiv.org/ content/early/2020/02/09/2020.02.06.20020974 [Last accessed on 01 Jan 2021].
50. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, et al. Diagnosing COVID-19: the disease and tools for detection. ACS Nano 2020;14:3822-35.
51. World Health Organization. Novel Coronavirus (2019-nCoV) situation REPORT-4; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200124-sitrep-4-2019-ncov.pdf?sfvrsn=9272d086_8 [Last accessed on 01 Jan 2021]
52. Li X, Zai J, Wang X, Li Y. Potential of large ‘first generation’ human-to-human transmission of 2019-nCoV. J Med Virol 2020;92:448-54.
53. Doremalen N van, Bushmaker T, Morris DH, Holbrook MG, Amandine Gamble, Brandi N Williamson, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382:1564-7.
54. Wadhwa P. Molecular docking study of novel covid-19 protease with current clinical management agents. Asian J Pharm Clin Res 2020;13:37–9.
55. Centers for Disease Control and Prevention. How COVID-19 Spreads; Vol. May. Centers for Disease Control and Prevention; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/faq.html#How-COVID-19-spreads [Last accessed on 01 Jan 2021]
56. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in germany. N Engl J Med 2020;383:970-1.
57. Phan LT, Nguyen TV, Luong QC, Nguyen TV, Le HQ, Nguyen TT, et al. Importation and human-to-human transmission of a novel coronavirus in vietnam. N Engl J Med. 2020;382:872-4.
58. Worldometer. COVID-19 coronavirus pandemic, 28 January 2021. Worldometer; 2021. p. 1–22. Available from: https://www.worldometers.info/coronavirus/ [Last accessed on 01 Jan 2021]
59. World Health Organization. COVID-19 Wly Epidemiological Update; 2021. Available from: https://www.who.int/docs/default-source/coronaviruse/ situation-reports/20201012-weekly-epi-update-9.pdf [Last accessed on 01 Jan 2021].
60. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report–48; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/ situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4 [Last accessed on 01 Jan 2021]
61. Tang B, Bragazzi NL, Li Q, Tang S, Xiao Y, Wu J, et al. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model 2020;5:248–55.
62. Cohen J, Kupferschmidt K. Strategies shift as coronavirus pandemic looms. Science 2020;367:962-3.
63. Regan H. Italy announces lockdown as global coronavirus cases surpass 105,000. CNN World; 2020. Available from: https://edition.cnn.com/2020/03/08/asia/coronavirus-covid-19-update-intl-hnk/index.html [Last accessed on 01 Jan 2021]
64. Kobayashi T, Jung S, Linton NM, Kinoshita R, Hayashi K, Miyama T, et al. Communicating the risk of death from novel coronavirus disease (COVID-19). J Clin Med 2020;9:1–7.
65. World Economic Forum. Key milestones in the spread of the coronavirus pandemic–a timeline. World Economic Forum; 2020. p. 1–15. Available from: https://www.weforum.org/agenda/2020/04/coronavirus-spread-covid19-pandemic-timeline-milestones/ [Last accessed on 01 Jan 2021]
66. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the diamond princess cruise ship, yokohama, Japan, 2020. Eurosurveillance 2020;25:1–5.
67. Stephen M Hahn. Coronavirus disease 2019 (COVID-19) update: foreign Inspections. U.S. Food and drug administration; 2020. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-disease-2019-covid-19-update-foreign-inspections [Last accessed on 01 Jan 2021]
68. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20.
69. Centers for Disease Control and Prevention. CDC 2019-novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel; 2020. Available from: https://www.fda.gov/media/ 134922/download [Last accessed on 01 Jan 2021].
70. Yang W, Yan F. Patients with RT-PCR confirmed COVID-19 and normal chest CT. Radiology 2020;295:17–9.
71. World Health Organization. Coronavirus disease 2019 (COVID-19) situation Report–179. Vol. 179. World Health Organization; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200717-covid-19-sitrep-179.pdf?sfvrsn=2f1599fa_2 [Last accessed on 01 Jan 2021]
72. Read JM, Bridgen JRE, Cummings DAT, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv 2020:1–11. https://doi.org/10.1101/2020.01.23.20018549
73. Worldometer. COVID-19 coronavirus pandemic. Worldometer; 2020. Available from: https://www.worldometers.info/ coronavirus/ [Last accessed on 01 Jan 2021]
74. Majumder MS, Mandl KD. Early transmissibility assessment of a novel coronavirus in Wuhan, China. SSRN; 2020.
75. Imai N, Cori A, Dorigatti I, Baguelin M, Donnelly CA, Riley S, et al. Report 3: Transmissibility of 2019-nCoV; 2020.
76. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020;6736:1–9.
77. World Health Organization. Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). World Health Organization; 2020. Available from: https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). [Last accessed on 01 Jan 2021]
78. Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020;92:214–7.
79. Manuel B, Richard K, Sarah T, H HH, F WA, A NR. 2019-novel coronavirus (2019-nCoV): estimating the case fatality rate–a word of caution. Swiss Med Wkly 2020:1–3. https://doi.org/10.4414/smw.2020.20203
80. World Health Organization. Novel coronavirus press conference at United Nations of Geneva; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-script-ncov-rresser-unog-29jan2020.pdf?sfvrsn=a7158807_4 [Last accessed on 01 Jan 2021]
81. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19-3 March 2020; 2020. Available from: https://www.who.int/ dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---3-march-2020. [Last accessed on 01 Jan 2021]
82. Worldometer. Coronavirus (COVID-19) Mortality Rate. Worldometer; 2020. Available from: https://www.worldometers.info/coronavirus/coronavirus-death-rate/#ref-12. [Last accessed on 01 Jan 2021]
83. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Vol. 2019; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. [Last accessed on 01 Jan 2021]
84. National Health Commission (NHC) of the People’s Republic of China. NHS Press Conference, Feb. 4 2020; 2020. Available from: http://www.nhc.gov.cn/xcs/xwbd/202002/35990d56cfcb43f4a70d7f9703b113c0.shtml. [Last accessed on 01 Jan 2021]
85. World Health Organization. Novel Coronavirus (2019-nCoV) situation report-7; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200127-sitrep-7-2019--ncov.pdf?sfvrsn=98ef79f5_2. [Last accessed on 01 Jan 2021]
86. Centres for Disease Control and Prevention. Symptoms of Coronavirus. Centres for Disease Control and Prevention; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc. gov%2Fcoronavirus%2F2019-ncov%2Fabout%2 Fsymptoms. html. [Last accessed on 01 Jan 2021]
87. Sun K, Chen J, Viboud C. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. Lancet 2020;2:201–8.
88. Worldometer. Coronavirus Incubation Period. Worldometer; 2020. Available from: https://www.worldometers.info/coronavirus/coronavirus-incubation-period/#asy. [Last accessed on 01 Jan 2021]
89. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill 2020;25:5.
90. Reuters. Coronavirus incubation could be as long as 27 d, Chinese provincial government says. Reuters; 2020. Available from: https://www.reuters.com/article/us-china-health-incubation/coronavirus-incubation-could-be-as-long-as-27-days-chinese-provincial-government-says-idUSKCN20G06W. [Last accessed on 01 Jan 2021]
91. Bai Y, Yao L, TaoWei, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. Am Med Assoc 2020;323:1406–7.
92. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report–75. Vol. 2019; 2020.
93. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report–88. Vol. 2019; 2020.
94. World Health Organization. Safe Ramadan practices in the context of the COVID-19. 2020. Available from: https://www.who.int/publications-detail/safe-ramadan-practices-in-the-context-of-the-covid-19-interim-guidance. [Last accessed on 01 Jan 2021]
95. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report–100. Vol. 2019; 2020.
96. Worldometer. COVID-19 coronavirus pandemic. Worldometer; 2020.
97. Worldometer. COVID-19 coronavirus pandemic. Worldometer; 2021. Available from: https://www.worldometers.info/coronavirus/. [Last accessed on 01 Jan 2021]
98. Worldometer. COVID-19 coronavirus pandemic. Worldometer; 2020. p. 1–22. Available from: https://www.worldometers.info/coronavirus/#news. [Last accessed on 21 Apr 2020]
99. World Health Organization. Coronavirus disease (COVID-19) situation report–102; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200501-covid-19-sitrep.pdf?sfvrsn=742f4a18_2. [Last accessed on 01 Jan 2021]
100. Ghosh P, Ghosh R, Chakraborty B. COVID-19 in India: statewise analysis and prediction. JMIR Public Heal Surveill; 2020;6:e20341–e20341.
101. PRS Legislative Researh. COVID-19 State wise data: India; 2021. p. 1–3. Available from: https://prsindia.org/covid-19/cases. [Last accessed on 01 Jan 2021]
102. Hindustan Times. Coronavirus: 4 northeast states untouched by Covid-19, no cases in Lakshadweep. Hindustan Times; 2020. p. 1–12. Available from: https://www. hindustantimes. com/india-news/coronavirus-4-northeast-states-untouched-by-covid-19-no-cases-in-lakshadweep/story-cb7jo3clLkGFJeMYPFpvGL.html. [Last accessed on 01 Jan 2021]
103. The Times of India. Covid-19: Govt bans all international flights to India from March 22 to 29 | India News-Times of India; 2020. p. 1–4. Available from: https://timesofindia.indiatimes.com/india/govt-bans-all-international-flights-to-india-from-march-22-to-29/articleshow/74720923.cms. [Last accessed on 01 Jan 2021]
104. My Gov Cell. COVID19 statewise status. National Informatics Centre (NIC); 2021. p. 1–2. Available from: https://www.mygov.in/corona-data/covid19-statewise-status/. [Last accessed on 01 Jan 2021]
105. World Health Organization. Emergencies preparedness, response: SARS-CoV-2 Variants; 2020. Available from: https://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/ [Last accessed on 01 Jan 2021]
106. World Health Organization. COVID-19: WHO European Region Operational Update Vol. 53; 2021. Available from: https://www.euro.who.int/__data/assets/pdf_file/0011/479396/WHO-Regional-Office-for-Europe-Operational-Update-Weeks-51-53-eng.pdf. [Last accessed on 01 Jan 2021]
107. European Centre for Disease Prevention and Control (ECDC). Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK–eighth update. Vol. 2019; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessment-coronavirus-disease-2019-eighth-update-8-april-2020.pdf. [Last accessed on 01 Jan 2021]
108. Worldometer. Coronavirus Cases Statistics and Charts. Worldometer. 2020[cited 2020 May 10]. Available from: https://www. worldometers. info/coronavirus/coronavirus-cases/. [Last accessed on 01 Jan 2021]
109. Worldometer. Coronavirus Graphs: Worldwide Cases and Deaths-Worldometer. Worldometer; 2021. p. 1–29. Available from: https://www.worldometers.info/coronavirus/worldwide-graphs/. [Last accessed on 01 Jan 2021]
110. Worldometer. COVID-19 coronavirus pandemic. Worldometer; 2020. Available from: https://www.worldometers.info/coronavirus/. [Last accessed on 10 May 2020]
111. Worldometer. Coronavirus Cases: Statistics and Charts-Worldometer. Vol. January 27, Worldometer; 2021. p. 1–12. Available from: https://www.worldometers. info/coronavirus/ coronavirus-cases/. [Last accessed on 01 Jan 2021]
112. Craven J. COVID-19 Vaccine Tracker. Regulatory Affairs Professionals Society (RAPS); 2021. p. 1–20. Available from: https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker. [Last accessed on 01 Jan 2021]
113. World Health Organization. Access and allocation: how will there be fair and equitable allocation of limited supplies? World Health Organization; 2021. p. 1–6. Available from: https://www.who.int/news-room/feature-stories/detail/access-and-allocation-how-will-there-be-fair-and-equitable-allocation-of-limited-supplies. [Last accessed on 01 Jan 2021]
114. World Health Organization. The different types of COVID-19 vaccines. World Health Organization; 2021. p. 1–6. Available from: https://www.who.int/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained.access and allocation: how will there be fair and equitable allocation of limited supplies. [Last accessed on 01 Jan 2021]
115. Nair KS, Kamath S, Rajan A, Thomas S, Aswin D, Zachariah SM. Detailed view on repurposed drugs, tracking of vaccines,and brief view on prophylactic nanomedicines as an alternative approach and patient care for covid-19. Int J Appl Pharm 2021;13:19–26.
116. Adnan N, Nordin SM, Anwar A. Transition pathways for Malaysian paddy farmers to sustainable agricultural practices: an integrated exhibiting tactics to adopt Green fertilizer. Land use policy. 2020;90:104255. Available from: https://doi.org/10.1016/j.landusepol.2019.104255. [Last accessed on 01 Jan 2021]
117. Elmi A, Sayem SAJ, Ahmed M, Mohamed F. Natural compounds from djiboutian medicinal plants as inhibitors of COVID-19 by in silico investigations. Int J Curr Pharm Res 2020;12:4.
118. University of Oxford. Oxford COVID-19 vaccine begins human trial stage. Oxford University Medical Sciences Division; 2020. Available from: https://www.ovg.ox.ac.uk/news/oxford-covid-19-vaccine-begins-human-trial-stage. [Last accessed on 01 Jan 2021]
119. UPMC. COVID-19 Vaccine Candidate Shows Promise. UPMC; 2020. Available from: https://www.upmc.com/media/news/040220-falo-gambotto-sars-cov2-vaccine. [Last accessed on 01 Jan 2021]
120. Novavax I. Novavax Identifies Coronavirus Vaccine Candidate; 2020. Available from: http://ir.novavax.com/news-releases/news-release-details/novavax-identifies-coronavirus-vaccine-candidate-accelerates#. [Last accessed on 01 Jan 2021]
121. Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv; 2020.
122. U. S. National Library of Medicine. Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine (BCG-CORONA). ClinicalTrials.gov; 2020. Available from: https://clinicaltrials.gov/ct2/show/study/NCT04328441. [Last accessed on 01 Jan 2021]
123. Zhang L, Liu Y. Potential Interventions for novel coronavirus in China: a systemic review. J Med Virol 2020;92:479–90.
124. Shrivastava A. Analytical methods for the determination of hydroxychloroquine in various matrices. Int J Appl Pharm 2020;12:55–61.
125. Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol 2003;32:567–82.
126. Bijlenga G. Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from the netherlands. J Infect 2005;51:263–5.
127. Marano G, Vaglio S, Pupella S, Facco G, Catalano L, Giancarlo M, et al. Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus 2016;14:152–7.
128. Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Omari A Al, Hameed FM Al, et al. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springer Plus 2015;4:1–8.
129. Soo YOY, Cheng Y, Wong R, Hui DS, Lee CK, Tsang KKS, et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Eur Soc Clin Microbiol Infect Dis 2004;10:676–8.
130. Wong YCR, Wong YOYSWS, Ng CKLMHL, Wong PCKC, Cheng CBLG. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 2005;24:44–6.
131. Velthuis AJW, Worm SHE Van Den, Sims AC, Baric RS, Snijder EJ, Hemert MJ Van. Zn 2+Inhibits coronavirus and arterivirus rna polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog 2010;6:e1001176.
Statistics
42 Views | 17 Downloads
Citations
How to Cite
ANWA, A., CHANDEL, V. S., SINGH, S. P., SINGH, S. P., & ANWAR, N. (2021). RISE AND FALL IN SARS-COV-2 GLOBAL PANDEMIC STRAIN RATE–AN OVERVIEW. International Journal of Applied Pharmaceutics, 13(3), 47-67. https://doi.org/10.22159/ijap.2021v13i3.40994
Section
Review Article(s)